2023
DOI: 10.1101/2023.04.16.537106
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

The pAblo·pCasso self-curing vector toolset for unconstrained cytidine and adenine base-editing in Gram-negative bacteria

Abstract: Pseudomonasspecies are platforms for chemical production. To unleash their potential as cell factories, we designed synthetic biology tools based on clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated protein 9 (Cas9) base-editors. A cytidine base-editor (CBE) and an adenine base-editor (ABE) were tailored for high-resolution genome engineering. CBE involves a cytidine deaminase fused to a nickase Cas9 fromStreptococcus pyogenes(SpnCas9) variant that converts cytidine to ur… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 83 publications
0
2
0
Order By: Relevance
“…Pablo Casasso has set a new benchmark in CRISPR-Cas technology by developing a toolkit that enables accurate and reversible DNA modifications in bacteria, thus method goes beyond the limitations of traditional CRISPR technology and significantly enhances industry and research capabilities to create bacterial cell factories. pAblopCasso facilitates the development of bacteria for various bio production applications, including pharmaceuticals and biofuels, aligned with sustainable production objectives, by enabling quick and accurate editing Ekaterina [38].…”
Section: Visionary Concepts Of Crispr/cas9 Technologymentioning
confidence: 99%
“…Pablo Casasso has set a new benchmark in CRISPR-Cas technology by developing a toolkit that enables accurate and reversible DNA modifications in bacteria, thus method goes beyond the limitations of traditional CRISPR technology and significantly enhances industry and research capabilities to create bacterial cell factories. pAblopCasso facilitates the development of bacteria for various bio production applications, including pharmaceuticals and biofuels, aligned with sustainable production objectives, by enabling quick and accurate editing Ekaterina [38].…”
Section: Visionary Concepts Of Crispr/cas9 Technologymentioning
confidence: 99%
“…It appears that there is potential for further optimization. Recently, cytidine deaminase‐based toolsets that enable efficient multiplex editing in P. putida have been developed (Kozaeva et al., 2024; Volke et al., 2022; Yue et al., 2022). However, this approach necessitates several prerequisites and can potentially introduce unknown mutations beyond the spacer region (Volke et al., 2022).…”
Section: Introductionmentioning
confidence: 99%